D
Celldex Therapeutics, Inc. CLDX
$21.85 -$0.08-0.37% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -70.78% 345.51% -71.56% 110.35% 832.09%
Total Other Revenue -- -- -- -- --
Total Revenue -70.78% 345.51% -71.56% 110.35% 832.09%
Cost of Revenue 36.56% 66.18% 54.27% 31.06% 51.18%
Gross Profit -43.77% -64.80% -74.04% -27.42% -43.12%
SG&A Expenses 13.84% 18.86% 16.20% 22.30% 26.41%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 32.31% 55.61% 45.71% 29.38% 45.83%
Operating Income -37.87% -54.50% -59.50% -26.40% -39.49%
Income Before Tax -57.92% -63.97% -8.74% -10.09% -17.51%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -57.92% -63.97% -8.74% -10.09% -17.51%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -57.92% -63.97% -8.74% -10.09% -17.51%
EBIT -37.87% -54.50% -59.50% -26.40% -39.49%
EBITDA -38.37% -55.33% -60.64% -26.85% -40.28%
EPS Basic -57.03% -45.42% 14.74% 21.51% 15.89%
Normalized Basic EPS -57.03% -45.42% -19.86% 21.52% 15.89%
EPS Diluted -57.03% -45.42% 14.74% 21.51% 16.48%
Normalized Diluted EPS -57.03% -45.42% -19.86% 21.52% 15.89%
Average Basic Shares Outstanding 0.56% 12.76% 27.53% 40.27% 39.71%
Average Diluted Shares Outstanding 0.56% 12.76% 27.53% 40.27% 39.71%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --